Given the very promising and specific SKOV3 viability reduction that we observed for anti-STAT3 mcDNA in the MTS assay, we proceeded to evaluate the underlying effects of our compound on apoptosis and necrosis in these representative ovarian cancer cells. Here, STAT3 is linked to ovarian carcinoma.